C
Cathoholic
Guest
‘Instant Coffee’ COVID-19 Tests Could Be the Answer to Reopening the U.S.
Cheap and quick, they could move us toward normalcy before a vaccine is widely availableBy Carolyn Barber on August 21, 2020
. . . America is a country looking for an answer to COVID-19 yesterday. And one might be available—if you can handle instant coffee rather than espresso.
The coffee analogy is one used by Michael Mina, assistant professor of epidemiology at the Harvard T. H. Chan School of Public Health, and it’s meant to describe the functional difference between two approaches to rapid testing for the virus. In this case, easy and cheap — instant coffee, that is—may very well be better.
“This is the most important potential tool that could exist today,” Mina said in a recent interview. “We pretty much have a different way…to stop community transmission in the absence of a vaccine—and it is sitting right in front of us.”
. . . If you had the option to test yourself in the morning by spitting into a tube (or swabbing your nose) and waiting 15 minutes for the results, and if it cost you no more than a couple of dollars . . .
Mina breaks down the existing tests into two camps. “Espresso coffee” tests are reverse transcriptase polymerase chain reaction (RT-PCR) tests or deluxe antigen tests, . . . These tests are highly sensitive . . .
In sharp contrast lie the “instant coffee” rapid paper antigen tests. . . These are fast, simple to use, at-home tests, and some are really inexpensive: about $1 to $5 per test. They are called lateral flow assays, but manifestly they are paper-strip tests that have an antibody embedded on filter paper. If a saliva sample has coronavirus present, the antibody will bind that viral antigen, turning the test positive, much like a pregnancy test works. Though the tests have much lower sensitivity than PCR tests overall, one advantage they have is that they do not detect leftover, inactive viral RNA particles, which may be present days to weeks after a person is infectious.
Here’s the key: What is more important than a perfect test is one that turns positive during the time period in which an individual can spread the virus to others—and that’s, purportedly, what these cheap tests do well. . . .
. . . Mina believes their sensitivity and performance would far exceed that of a single PCR test. . . . public health surveillance depends much more on frequency of testing and rapid reporting of results than it does on the comparative sensitivity of the tests themselves. . . .
. . . we could very quickly get this pandemic under control. . . .
. . . Why haven’t we seen them in the drug stores? The answer is that the FDA is holding developers of these tests, like E25Bio, to the same high sensitivity standards as those required for molecular grade diagnostics. Without being granted an EUA, the companies are not manufacturing the tests. Mina and others argue that a paradigm shift is needed, so that rapid antigen tests are recognized as a “public health tool," . . .
Bold mine.
Last edited: